Orchestra BioMed Holdings Inc (OBIO) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Medical device industry veteran brings over three decades of expertise in M&A, as well as structured...

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

NEW HOPE, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra...

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra...

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form EFFECT - Notice of Effectiveness